Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01977001
Other study ID # 12-3542
Secondary ID
Status Completed
Phase N/A
First received October 24, 2013
Last updated October 23, 2014
Start date November 2012
Est. completion date June 2014

Study information

Verified date October 2014
Source Minneapolis Medical Research Foundation
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

MigraineBoxTM is a simple, contoured cooling bath for the head and neck. Effectiveness of MigraineBoxTM will be studied in primary headaches in the emergency department. The user simply reclines his/her head and neck into this device that has contours that support the head and neck. Luke warm water is filled into the MigraineBoxTM before use and then a frozen insert is placed inside. This will gradually cool the water surrounding the patient's head and theoretically provide headache relief.


Recruitment information / eligibility

Status Completed
Enrollment 29
Est. completion date June 2014
Est. primary completion date June 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- 18-85 years old

- Benign headache

- Physician intends to treat headache pain in the ED with either droperidol, prochlorperazine, or a parenteral narcotic

Exclusion Criteria:

- Unable to provide informed consent

- Headache due to trauma, subarachnoid hemorrhage, meningitis, intracerebral bleed, cranial tumor, sinusitis, dental pathology, temporomandibular joint dysfunction, glaucoma, or systemic infection

- Known renal impairment

- Known hepatic impairment

- A history of coronary artery disease, peripheral vascular disease, or cerebrovascular disease

- Perforated ear drum

- Pregnant

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Device:
MigraineBoxTM


Locations

Country Name City State
United States Hennepin County Medical Center Minneapolis Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Minneapolis Medical Research Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline in Pain Level Patients will be asked to complete a 100 mm visual analog scale and a four point Likert scale concerning their pain. Baseline, 30 minutes, 60 minutes No
Secondary Change from Baseline in Nausea Patients will be asked to complete a 100 mm visual analog scale concerning their level of nausea. Baseline, 30 minutes, 60 minutes No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06277063 - nVNS for the Prevention and Treatment of Primary Headache N/A
Completed NCT02031822 - Two US-guided Techniques for Greater Occipital Nerve Blocks N/A